tiprankstipranks
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
US Market
TERN
Terns Pharmaceuticals
RESEARCH TOOLSreports

Terns Pharmaceuticals (TERN) Financial Statements

543 Followers

Terns Pharmaceuticals Financial Overview

Terns Pharmaceuticals's market cap is currently $6.09B. The company's EPS TTM is $-0.255; its P/E ratio is -39.12; Terns Pharmaceuticals is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00M
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00M
Operating Income$ -110.12M$ -101.87M$ -102.56M$ -62.03M$ -49.86M
EBITDA$ -110.12M$ -100.97M$ -101.68M$ -61.00M$ -49.35M
Net Income$ -96.21M$ -88.85M$ -90.21M$ -60.34M$ -50.16M
Balance Sheet
Cash & Short-Term Investments$ 1.02B$ 358.16M$ 263.44M$ 283.11M$ 165.98M
Total Assets$ 1.03B$ 363.93M$ 268.52M$ 287.03M$ 168.07M
Total Debt$ 919.00K$ 1.35M$ 603.00K$ 1.21M$ 0.00
Net Debt$ -523.83M$ -160.09M$ -79.32M$ -142.03M$ -47.70M
Total Liabilities$ 18.55M$ 18.06M$ 13.15M$ 10.08M$ 7.77M
Stockholders' Equity$ 1.01B$ 345.87M$ 255.37M$ 276.94M$ 160.30M
Cash Flow
Free Cash Flow$ -82.18M$ -70.06M$ -67.44M$ -49.38M$ -42.17M
Operating Cash Flow$ -82.18M$ -70.02M$ -67.39M$ -49.11M$ -41.83M
Investing Cash Flow$ -298.04M$ -12.41M$ -37.99M$ -22.27M$ -119.70M
Financing Cash Flow$ 743.51M$ 164.00M$ 41.95M$ 167.09M$ 134.39M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

Income Statement >

Terns Pharmaceuticals Debt to Assets

Balance Sheet >

Terns Pharmaceuticals Cash Flow

Cash Flow >

Terns Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >